Xenoblade Chronicles 2 Becomes Highest Selling Xeno Game

Thursday, April 26th, 2018

Tokyo NECRO is out now from JAST

Look for us on OpenCritic!

Share this page

Pre Order How a Healthy Hentai Administers Public Service at MangaGamer

Revisit the oldest and greatest Visual Novel Forum, now under new leadership!

We are proudly a Play-Asia Partner

SUPPORT OPRAINFALL BY TURNING OFF ADBLOCK

Ads support the website by covering server and domain costs. We're just a group of gamers here, like you, doing what we love to do: playing video games and bringing y'all niche goodness. So, if you like what we do and want to help us out, make an exception by turning off AdBlock for our website. In return, we promise to keep intrusive ads, such as pop-ups, off oprainfall. Thanks, everyone!

By


Xenoblade Chronicles 2

Monolith Soft is really feeling it these days. Xenoblade Chronicles 2, which released back in December, has now sold 1.31 million copies worldwide.

Not only has that surpassed sales of the original Xenoblade Chronicles and Xenoblade Chronicles X, but it has also surpassed all other Xeno games, such as Xenogears and any of the Xenosaga titles. Xenogears sold a total of 1.19 million copies worldwide. Xenosaga Episode I: Der Wille zur Macht also sold over 1 million copies worldwide. Xenosaga Episode III: Also Sprach Zarathustra, however, only sold 343,000 copies in Japan, North America, and Asia combined. The power of Xeno is strong these days.

Xenoblade Chronicles 2 isn’t stopping there though. Patch 1.4.0 releases Friday, which adds another character from Xenosaga, T-elos, as an unlockable Blade. Also, a new DLC Blade, Poppy Buster, from the Season Pass will also be available for download.

About Tyler Trosper

Tyler Trosper graduated Ball State University with a major in Creative Writing and a minor in Professional Writing. Originally joining Operation Rainfall as an anime news writer, he also writes gaming news and dabbles in reviews. His one true love in life is Xenosaga, and he prays daily for a fourth game.